124 related articles for article (PubMed ID: 38831605)
1. Determinants of the haemoglobin level in patients with sickle cell disease living in sub-Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis.
Rossi M; Belinga S; Tolo A; Diop S; Diagne I; Chelo D; Wamba G; Gonzalez JP; Abough'elie C; Traore Y; Deme-Ly I; Seck M; Diaw M; Gbonon V; Boidy K; Kamara I; Kitenge R; Jouven X; Tshilolo L; Diallo D; Ranque B
Br J Haematol; 2024 Jun; ():. PubMed ID: 38831605
[TBL] [Abstract][Full Text] [Related]
2. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study.
Ranque B; Menet A; Diop IB; Thiam MM; Diallo D; Diop S; Diagne I; Sanogo I; Kingue S; Chelo D; Wamba G; Diarra M; Anzouan JB; N'Guetta R; Diakite CO; Traore Y; Legueun G; Deme-Ly I; Belinga S; Boidy K; Kamara I; Tharaux PL; Jouven X
Lancet Haematol; 2014 Nov; 1(2):e64-73. PubMed ID: 27030156
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of growth failure in young African patients with sickle cell disease.
Alexandre-Heymann L; Dubert M; Diallo DA; Diop S; Tolo A; Belinga S; Sanogo I; Diagne I; Wamba G; Boidy K; Ly ID; Kamara I; Traore Y; Offredo L; Jouven X; Ranque B
Br J Haematol; 2019 Jan; 184(2):253-262. PubMed ID: 30467843
[TBL] [Abstract][Full Text] [Related]
4. Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study.
Ranque B; Kitenge R; Ndiaye DD; Ba MD; Adjoumani L; Traore H; Coulibaly C; Guindo A; Boidy K; Mbuyi D; Ly ID; Offredo L; Diallo DA; Tolo A; Kafando E; Tshilolo L; Diagne I
Lancet Haematol; 2022 Mar; 9(3):e208-e216. PubMed ID: 35240076
[TBL] [Abstract][Full Text] [Related]
5. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
6. Arterial Stiffness Impairment in Sickle Cell Disease Associated With Chronic Vascular Complications: The Multinational African CADRE Study.
Ranque B; Menet A; Boutouyrie P; Diop IB; Kingue S; Diarra M; N'Guetta R; Diallo D; Diop S; Diagne I; Sanogo I; Tolo A; Chelo D; Wamba G; Gonzalez JP; Abough'elie C; Diakite CO; Traore Y; Legueun G; Deme-Ly I; Faye BF; Seck M; Kouakou B; Kamara I; Le Jeune S; Jouven X
Circulation; 2016 Sep; 134(13):923-33. PubMed ID: 27582423
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease.
Quinn CT; Ahmad N
Br J Haematol; 2005 Oct; 131(1):129-34. PubMed ID: 16173973
[TBL] [Abstract][Full Text] [Related]
9. Quantitative MRI evaluation of bone marrow in sickle cell disease: relationship with haemolysis and clinical severity.
Lins CF; Salmon CEG; Amorim de Souza L; Quesado RCS; de Souza Moraes R; Silva-Pinto AC; Matos MA; Nogueira-Barbosa MH
Clin Radiol; 2023 Mar; 78(3):e268-e278. PubMed ID: 36623977
[TBL] [Abstract][Full Text] [Related]
10. The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease.
Kupesiz A; Celmeli G; Dogan S; Antmen B; Aslan M
Free Radic Res; 2012 Jul; 46(7):883-90. PubMed ID: 22509726
[TBL] [Abstract][Full Text] [Related]
11. Haematological determinants of cardiac involvement in adults with sickle cell disease.
Damy T; Bodez D; Habibi A; Guellich A; Rappeneau S; Inamo J; Guendouz S; Gellen-Dautremer J; Pissard S; Loric S; Wagner-Ballon O; Godeau B; Adnot S; Dubois-Randé JL; Hittinger L; Galactéros F; Bartolucci P
Eur Heart J; 2016 Apr; 37(14):1158-1167. PubMed ID: 26516176
[TBL] [Abstract][Full Text] [Related]
12. Iron deficiency anaemia in Jamaican children, aged 1-5 years, with sickle cell disease.
King L; Reid M; Forrester TE
West Indian Med J; 2005 Oct; 54(5):292-6. PubMed ID: 16459510
[TBL] [Abstract][Full Text] [Related]
13. Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.
Brandow AM; Wandersee NJ; Dasgupta M; Hoffmann RG; Hillery CA; Stucky CL; Panepinto JA
Br J Haematol; 2016 Oct; 175(2):237-245. PubMed ID: 27539682
[TBL] [Abstract][Full Text] [Related]
14. Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
Dembélé AK; Lapoumeroulie C; Diaw M; Tessougue O; Offredo L; Diallo DA; Diop S; Elion J; Colin-Aronovicz Y; Tharaux PL; Jouven X; Romana M; Ranque B; Le Van Kim C
Br J Haematol; 2021 Feb; 192(3):634-642. PubMed ID: 33249569
[TBL] [Abstract][Full Text] [Related]
15. Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana.
Zempsky WT; Yanaros M; Sayeem M; Boruchov D; Piccone CM; Manwani D; Strunk C; Tartaglione I; Colombatti R; Akatue S; Oteng B; Owda A; Bamfo R; Wilson S; Rivers A; Farooq F; Urbonya R; Boatemaa GD; Rao S; Inusa B; Antwi-Boasiako C; Segbefia C; Sey F; Andemariam B; Asare EV; Campbell AD
Pain Med; 2022 Aug; 23(8):1379-1386. PubMed ID: 35166851
[TBL] [Abstract][Full Text] [Related]
16. Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.
Nouraie M; Reading NS; Campbell A; Minniti CP; Rana SR; Luchtman-Jones L; Kato GJ; Gladwin MT; Castro OL; Prchal JT; Gordeuk VR
Br J Haematol; 2010 Jul; 150(2):218-25. PubMed ID: 20507315
[TBL] [Abstract][Full Text] [Related]
17. Investigations of Kidney Dysfunction-Related Gene Variants in Sickle Cell Disease Patients in Cameroon (Sub-Saharan Africa).
Ngo-Bitoungui VJ; Belinga S; Mnika K; Masekoameng T; Nembaware V; Essomba RG; Ngo-Sack F; Awandare G; Mazandu GK; Wonkam A
Front Genet; 2021; 12():595702. PubMed ID: 33790942
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of raised body mass index in paediatric sickle cell disease.
Jackson E; Karlson CW; Herring W; Okhomina VI; Lim CS; Morrow A; Daggett C; Arnold L; McNaull M
J Paediatr Child Health; 2022 Oct; 58(10):1829-1835. PubMed ID: 35822947
[TBL] [Abstract][Full Text] [Related]
20. Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia.
Ferguson SK; Redinius K; Yalamanoglu A; Harral JW; Hyen Baek J; Pak D; Loomis Z; Hassell D; Eigenberger P; Nozik-Grayck E; Nuss R; Hassell K; Stenmark KR; Buehler PW; Irwin DC
J Physiol; 2019 Feb; 597(4):1073-1085. PubMed ID: 29931797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
